Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.62
-0.05 (-0.65%)
Aug 27, 2026, 10:36 AM EDT - Market open
Exagen Market Cap
Exagen has a market cap or net worth of $184.6 million as of August 27, 2026. Its market cap has decreased by -15.26% in one year.
Market Cap
184.60M
Enterprise Value
187.67M
1-Year Change
-15.26%
Ranking
Category
Stock Price
$7.62
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $184.60M, an increase of 192.52%. That is a compound annual growth rate of 16.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 184.60M | 33.97% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.51B |
| OPKO Health | 1.13B |
| Castle Biosciences | 1.04B |
| Fulgent Genetics | 545.08M |
| Biodesix | 322.86M |
| Myriad Genetics | 298.43M |
| Insight Molecular Diagnostics | 140.71M |
| Quantum Cyber | 115.59M |